Castrate Resistant Prostate Cancer Market is Estimated To Witness...

added article Other

2023-12-01 06:28:09 -

Castrate Resistant Prostate Cancer Market is Estimated To Witness High Growth Owing To Increased Castrate Resistant Prostate Cancer Incidences

The Castrate Resistant Prostate Cancer Market is estimated to be valued at US$ 11.12 Bn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The castrate resistant prostate cancer market comprises drugs used for treatment of prostate cancer that has spread to other parts of the body even...

0 Comments 0 Shares 977 Views 0 Reviews